Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway

<div>MDA-MB-231-derived EVs can induce drug resistance by carrying miR-887-3p into breast cancer cells to inhibit BTBD7 expression and activate the Notch1/Hes1 signaling pathway.</div>

Disease Markers

fig8

Figure 8

Figure 8: Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway 

Figure 8 | Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway 